Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, Leroi I, Pozo-Rodriguez F, Minthon L, Londos E.

Lancet Neurol. 2009 Jul;8(7):613-8. doi: 10.1016/S1474-4422(09)70146-2. Epub 2009 Jun 10.

PMID:
19520613
2.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
3.

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.

Wang HF, Yu JT, Tang SW, Jiang T, Tan CC, Meng XF, Wang C, Tan MS, Tan L.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):135-43. doi: 10.1136/jnnp-2014-307659. Epub 2014 May 14. Review.

PMID:
24828899
4.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
5.

Cholinesterase inhibitors for dementia with Lewy bodies.

Wild R, Pettit T, Burns A.

Cochrane Database Syst Rev. 2003;(3):CD003672. Review.

PMID:
12917981
6.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(1):CD003154. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD003154.

PMID:
12535459
7.

Treatment of dementia with Lewy bodies and Parkinson's disease dementia.

Ballard C, Kahn Z, Corbett A.

Drugs Aging. 2011 Oct 1;28(10):769-77. doi: 10.2165/11594110-000000000-00000. Review.

PMID:
21970305
8.

Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies.

Camicioli R, Gauthier S.

Can J Neurol Sci. 2007 Mar;34 Suppl 1:S109-17. Review.

PMID:
17469693
9.

[Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].

Drach LM.

Med Monatsschr Pharm. 2011 Feb;34(2):47-52; quiz 53-4. Review. German.

PMID:
21428015
10.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003154.

PMID:
15846650
11.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003154.

PMID:
16034889
12.

Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.

Francis PT.

J Neurol. 2009 Aug;256 Suppl 3:280-5. doi: 10.1007/s00415-009-5247-7. Review.

PMID:
19711117
13.

Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease.

Burn DJ, McKeith IG.

Mov Disord. 2003 Sep;18 Suppl 6:S72-9. Review.

PMID:
14502659
14.

Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.

Aarsland D, Mosimann UP, McKeith IG.

J Geriatr Psychiatry Neurol. 2004 Sep;17(3):164-71. Review.

PMID:
15312280
15.

Cholinesterase inhibitors for Parkinson's disease dementia.

Maidment I, Fox C, Boustani M.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004747. Review.

PMID:
16437494
16.

Memantine for dementia.

McShane R, Areosa Sastre A, Minakaran N.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154. Review.

PMID:
16625572
17.

Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.

Emre M, Cummings JL, Lane RM.

J Alzheimers Dis. 2007 Jul;11(4):509-19. Review.

PMID:
17656830
18.

Memantine for dementia.

Areosa Sastre A, McShane R, Sherriff F.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD003154.

PMID:
15495043
19.

Donepezil for vascular cognitive impairment.

Malouf R, Birks J.

Cochrane Database Syst Rev. 2004;(1):CD004395. Review.

PMID:
14974068
20.

Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.

Aarsland D.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S144-8. doi: 10.1016/j.parkreldis.2015.09.034. Epub 2015 Sep 21. Review.

PMID:
26411499

Supplemental Content

Support Center